Sterigenics invests US$10m in US irradiation facility
Growing customer demand drives expansion in the American Midwest
Sterigenics, the leading global provider of contract sterilisation, gamma technologies and medical isotopes, has announced a US$10m expansion at its facility in Gurnee, Illinois, US to add a new gamma cell.
The irradiator will be ready for customer product validation in October of this year, with production to follow immediately.
‘Aligning our capital investments to support our customers’ growth strategies has always been a top priority for our company,’ said Michael Mulhern, CEO of Sterigenics. ‘Customers can expect Sterigenics to continue to add valuable global sterilisation capacity going forward.’
‘Growing customer demand is driving this expansion,’ said Philip Macnabb, President of Sterigenics. ‘With this addition, we are adding gamma processing capacity of up to 5 million cubic feet per year in the Midwestern United States.’
The cell is modelled after Sterigenics’ other tote systems with dimensions of 24 x 48 x 40 inches. The product overlap system is extremely efficient and provides the capability to process numerous dose ranges and a wide variety of densities.
